AbbVie | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
Abbott USD 40.03B 468M 2024-12
ALKERMES USD 1.46B 172.88M 2024-12
Amgen USD 5.88B 1.65B 2024-12
AstraZeneca USD 40.87B 66M 2024-12
Biogen USD 16.72B 357.1M 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Eisai JPY 873.36B 53.3B 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 13.67B 218M 2024-12
J&J USD 71.49B 1.33B 2024-12
Medtronic USD 49.39B 893M 2025-01
Merck USD 46.31B 1.81B 2024-12
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 605M 2024-12
Pacira USD 778.35M 28.76M 2024-12
Perrigo USD 4.32B 246.6M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Regeneron Pharmaceuticals USD 29.35B 27.7M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 73B 1.36B 2024-06
UCB EUR 10.03B 1.08B 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
United Therapeutics USD 6.44B 343.1M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12
Zoetis USD 4.77B 464M 2024-12



AbbVie Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.